$12.90
-0.05-0.39%
Last update: May 19, 8:12 AM
Atrium Therapeutics Inc Earnings Estimates
RNANASDAQ
Earnings: Q1 2026 Earnings were released on Thu May 14th, after the market close
Atrium Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:RNA
Atrium Therapeutics (RNA) is scheduled to report Q4 earnings on June 2, 2026. Analysts estimate EPS of $-1.09 and quarterly revenue of $2.00M.
In the most recent quarter (Q1), Atrium Therapeutics reported EPS of $-0.97, beating estimates of $-1.10 by 0.12%. Revenue came in at $19.64M, exceeding the estimate of $2.00M by 8.82%.
Over the last 4 quarters, Atrium Therapeutics has averaged an EPS surprise of 0.15% and a revenue surprise of 3.85%.
Earnings Date
Jun 2
EPS Estimate
$-1.090
Quarterly Revenue Estimate
$2.00M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$36.68M
Atrium Therapeutics Earnings History
Analyze the earnings history of Atrium Therapeutics using advanced sorting and filters.
Loading calendar...
Atrium Therapeutics (RNA) Earnings Per Share
The chart below shows Atrium Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Atrium Therapeutics (RNA) Revenue
The chart below shows Atrium Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Atrium Therapeutics (NASDAQ:RNA) reporting earnings?
Atrium Therapeutics (RNA) is scheduled to report earnings on June 2, 2026. The last reported earnings were for reported on May 14, 2026 for Q1.
What were the latest earnings per share (EPS) for Atrium Therapeutics (NASDAQ:RNA)?
The Actual EPS was $-0.97, which beat the estimate of $-1.10.
What were Atrium Therapeutics’s (NASDAQ:RNA) revenues?
The Actual Revenue was $19.64M, which beat the estimate of $2.00M.
